Response of Unvaccinated US Adults to Official Information About the Pause in Use of the Johnson & Johnson-Janssen COVID-19 Vaccine: Cross-Sectional Survey Study.

Publication date: Apr 01, 2024

Using a rapid response web-based survey, we identified gaps in public understanding of the Centers for Disease Control and Prevention’s messaging about the pause in use of the Johnson & Johnson-Janssen COVID-19 vaccine and estimated changes in vaccine hesitancy using counterfactual questions.

Open Access PDF

Concepts Keywords
Adults CDC
Covid COVID-19
Janssen health communication
Vaccine health information
Web health literacy
public health
risk perception
vaccine hesitancy
web-based surveys


Type Source Name
disease VO unvaccinated
disease VO COVID-19 vaccine
disease VO vaccine
disease MESH COVID 19
disease VO vaccinated
disease VO population
disease VO vaccination
disease MESH Educational attainment
disease IDO quality
disease MESH uncertainty
disease VO effective
drug DRUGBANK Isoxaflutole
disease VO Gap
disease VO adverse event
disease VO Ad26.COV2.S

Original Article

(Visited 1 times, 1 visits today)